Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
313
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
+597K
-
Total reported value, excl. options
-
$4.59B
-
Value change
-
+$104M
-
Put/Call ratio
-
0.17
-
Number of buys
-
136
-
Number of sells
-
-165
-
Price
-
$164.05
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q1 2021
359 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q1 2021.
Medpace Holdings, Inc. - Common Stock (MEDP) has 313 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 30.9M outstanding shares and own 90.64% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.87M shares), VANGUARD GROUP INC (3.31M shares), WASATCH ADVISORS INC (2.65M shares), Invesco Ltd. (899K shares), STATE STREET CORP (829K shares), PRICE T ROWE ASSOCIATES INC /MD/ (757K shares), Pendal Group Limited (628K shares), DIMENSIONAL FUND ADVISORS LP (599K shares), Boston Trust Walden Corp (543K shares), and GEODE CAPITAL MANAGEMENT, LLC (496K shares).
This table shows the top 313 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.